Quantcast
Home / Practice Areas / Business and Civil Practice / Federal Circuit ruling a win for biotech field

Federal Circuit ruling a win for biotech field

In a second victory for the biotech industry in one year, the Federal Circuit has reinstated its ruling that a company’s isolation of human genetic material, and its process for using that material to determine the effectiveness of certain cancer therapies, meet the threshold test for patent-eligibility.
Scroll To Top